146 related articles for article (PubMed ID: 26680318)
21. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
Cui J; Yu B; Zhao Y; Zhu W; Li H; Lou H; Zhai G
Int J Pharm; 2009 Apr; 371(1-2):148-55. PubMed ID: 19124065
[TBL] [Abstract][Full Text] [Related]
22. A Novel Self-Microemulsifying System for the Simultaneous Delivery and Enhanced Oral Absorption of Curcumin and Resveratrol.
Jaisamut P; Wiwattanawongsa K; Wiwattanapatapee R
Planta Med; 2017 Mar; 83(5):461-467. PubMed ID: 27280934
[TBL] [Abstract][Full Text] [Related]
23. Improvement of Anti-Hyperlipidemic Activity and Oral Bioavailability of Fluvastatin Via Solid Self-Microemulsifying Systems and Comparative with Liquisolid Formulation.
Madhav KV; Kishan V
Curr Drug Deliv; 2018; 15(9):1245-1260. PubMed ID: 30033871
[TBL] [Abstract][Full Text] [Related]
24. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
[TBL] [Abstract][Full Text] [Related]
25. Solubilized formulation of olmesartan medoxomil for enhancing oral bioavailability.
Lee BS; Kang MJ; Choi WS; Choi YB; Kim HS; Lee SK; Lee J; Choi YW
Arch Pharm Res; 2009 Nov; 32(11):1629-35. PubMed ID: 20091278
[TBL] [Abstract][Full Text] [Related]
26. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.
Li F; Song S; Guo Y; Zhao Q; Zhang X; Pan W; Yang X
Drug Deliv; 2015; 22(4):487-98. PubMed ID: 24524289
[TBL] [Abstract][Full Text] [Related]
27. Lipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluation.
Boakye CH; Patel K; Patel AR; Faria HA; Zucolotto V; Safe S; Singh M
Drug Deliv Transl Res; 2016 Oct; 6(5):526-39. PubMed ID: 27405772
[TBL] [Abstract][Full Text] [Related]
28. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.
Lu JL; Wang JC; Zhao SX; Liu XY; Zhao H; Zhang X; Zhou SF; Zhang Q
Eur J Pharm Biopharm; 2008 Aug; 69(3):899-907. PubMed ID: 18434109
[TBL] [Abstract][Full Text] [Related]
29. Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility.
Bolko K; Zvonar A; Gašperlin M
Drug Dev Ind Pharm; 2014 Jan; 40(1):102-9. PubMed ID: 23301796
[TBL] [Abstract][Full Text] [Related]
30. Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.
Dokania S; Joshi AK
Drug Deliv; 2015; 22(6):675-90. PubMed ID: 24670091
[TBL] [Abstract][Full Text] [Related]
31. [Drug delivery systems of baicalin, baicalin-phospholipid complex and self-microemulsifying drug across Caco-2 cell model].
Chen L; Long XY; Huang SH; Wu HY; Pan SJ
Zhong Yao Cai; 2012 May; 35(5):757-61. PubMed ID: 23213740
[TBL] [Abstract][Full Text] [Related]
32. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Biopharm; 2008 Oct; 70(2):439-44. PubMed ID: 18603415
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems.
Kim GG; Poudel BK; Marasini N; Lee DW; Hiep TT; Yang KY; Kim JO; Yong CS; Choi HG
Drug Dev Ind Pharm; 2013 Sep; 39(9):1431-8. PubMed ID: 23046292
[TBL] [Abstract][Full Text] [Related]
34. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.
Shen H; Zhong M
J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176
[TBL] [Abstract][Full Text] [Related]
35. Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies.
Singh G; Pai RS
Drug Deliv; 2015; 22(4):522-30. PubMed ID: 24512464
[TBL] [Abstract][Full Text] [Related]
36. Oral absorption and lymphatic transport of baicalein following drug-phospholipid complex incorporation in self-microemulsifying drug delivery systems.
Liao H; Gao Y; Lian C; Zhang Y; Wang B; Yang Y; Ye J; Feng Y; Liu Y
Int J Nanomedicine; 2019; 14():7291-7306. PubMed ID: 31564878
[TBL] [Abstract][Full Text] [Related]
37. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone.
Kim HJ; Yoon KA; Hahn M; Park ES; Chi SC
Drug Dev Ind Pharm; 2000 May; 26(5):523-9. PubMed ID: 10789064
[TBL] [Abstract][Full Text] [Related]
38. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
Yin YM; Cui FD; Mu CF; Choi MK; Kim JS; Chung SJ; Shim CK; Kim DD
J Control Release; 2009 Dec; 140(2):86-94. PubMed ID: 19709639
[TBL] [Abstract][Full Text] [Related]
39. Nano scale self-emulsifying oil based carrier system for improved oral bioavailability of camptothecin derivative by P-Glycoprotein modulation.
Negi LM; Tariq M; Talegaonkar S
Colloids Surf B Biointerfaces; 2013 Nov; 111():346-53. PubMed ID: 23850745
[TBL] [Abstract][Full Text] [Related]
40. Enhanced oral bioavailability of valsartan using a polymer-based supersaturable self-microemulsifying drug delivery system.
Yeom DW; Chae BR; Son HY; Kim JH; Chae JS; Song SH; Oh D; Choi YW
Int J Nanomedicine; 2017; 12():3533-3545. PubMed ID: 28507434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
